Tarantula venom has painkiller potential - WSPA.com

Tarantula venom has painkiller potential

Updated: Feb 25, 2014 02:50 PM
© CDC © CDC
  • HealthMore>>

  • Most adults are members of 'clean plate club'

    Most adults are members of 'clean plate club'

    Unlike children, the vast majority of adults finish all of the food they put on their plate at mealtime, according to a new study.
    Unlike children, the vast majority of adults finish all of the food they put on their plate at mealtime, according to a new study.
  • The 'Hobby Lobby ruling' and what it means for U.S. health care

    The 'Hobby Lobby ruling' and what it means for U.S. health care

    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
  • Diet changes can alter gut bacteria

    Diet changes can alter gut bacteria

    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.

TUESDAY, Feb. 25, 2014 (HealthDay News) -- Tarantula venom may hold the key to the development of a safe and effective new painkiller, according to a new study.

Yale University researchers found that a specific protein in the venom of the Peruvian green velvet tarantula blocks activity in nerve cells that transmit pain. They say the process they used to identify this protein could also search for millions of different spider toxins and lead to the development of other new pain medications.

"The likelihood is that within the vast diversity of spider toxins we will find others that are active against other channels important for pain," senior study author Michael Nitabach said in a Yale news release.

"The beauty of the system is we can also screen engineered toxins not found in nature," added Nitabach, an associate professor of cellular and molecular physiology and of genetics. By doing so, he said, they could identify more potent variations that would not harm essential nerve functions.

For the study published in the March 3 issue of Current Biology, the researchers analyzed more than 100 spider toxins from various tarantula species. They tested these toxins on "TRPA1" -- one of 12 suspected human pain channels. Located on the surface of nerve cells that sense pain, this channel is associated with inflammation and nerve pain.

The researchers found the one tarantula toxin, in particular, that blocked this pain channel but did not affect any other channels on the surface of nerve cells.

They say they plan to continue testing many thousands of new toxins that could produce similar pain-reducing effects.

More information

Visit the American Museum of Natural History to learn how various toxins may be used to develop new drugs and medical treatments.

Copyright © 2014 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

250 International Dr.
Spartanburg, S.C. 29303

Telephone: 864.576.7777
Fax: 864.587.5430
Email: webmaster@wspa.com

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Media General Communications Holdings, LLC. A Media General Company.